Using rare diseases as models for biobehavioral research: Allergic bronchopulmonary aspergillosis

Allergy and Asthma Proceedings

Volumn 28, Issue 4, 2007, Pages 489-496

  Greenberger, Paul A ^a   Yucha, Carolyn B ^b   Janson, Susan ^c   Huss, Karen ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF NEVADA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

Author keywords

ABPA; Aspergillosis; Biobehavioral; Disease model; Interdisciplinary; Natural history; Prevalence; Staging; Susceptibility; Treatment

Indexed keywords

ARTICLE; BEHAVIOR; BIOLOGICAL MODEL; CONSENSUS DEVELOPMENT; HUMAN; LUNG ASPERGILLOSIS; MEDICAL RESEARCH; PHYSIOLOGY; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; RARE DISEASE;

ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; BEHAVIOR; BIOMEDICAL RESEARCH; HUMANS; MODELS, BIOLOGICAL; PRACTICE GUIDELINES AS TOPIC; RARE DISEASES;

EID: 34548642661     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2007.28.3023     Document Type: Article

References (37)

1. Schwartz HJ, and Greenberger PA. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med 117:138-142, 1991.
2. Malo JL, and Paquin R. Incidence of immediate sensitivity to Aspergillus fumigatus in a North American asthmatic population. Clin Allergy 9:377-384, 1979.
3. Benatar SR, Keen GA, and Du Toit Naude W. Aspergillus hypersensitivity in asthmatics in Cape Town. Clin Allergy 10:285-291, 1980.
4. Maurya V, Gugnani HC, Sarma PU, et al. Sensitization of Aspergillus antigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma. Chest 127:1257-1259, 2005.
5. Greenberger PA, and Patterson R. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 81:646-650, 1988.
6. Slavin RG, Laird TS, and Cherry JD. Allergic bronchopulmonary aspergillosis in a child. J Pediatr 76:416-421, 1970.
7. Hart RJ, Patterson R, and Sommers H. Hyperimmunoglobulemia E in a child with allergic bronchopulmonary aspergillosis and bronchiectasis. J Allergy Clin Immunol 89:38-41, 1976.
8. Kiefer TA, Kesarwala HH, Greenberger PA, et al. Allergic bronchopulmonary aspergillosis in a young child: Diagnostic confirmation by serum IgE and IgG indices. Ann Allergy 56:233-236, 1986.
9. Imbeau SA, Cohen M, and Reed CE. Allergic bronchopulmonary aspergillosis in infants. Am J Dis Child 131:1127-1130, 1977.
10. Malo JL, Hawkins R, and Pepys J. Studies in chronic allergic bronchopulmonary aspergillosis, I. Clinical and physiologic findings. Thorax 32:254-261, 1977.
11. Turner ES, Greenberger PA, and Sider L. Complexities of establishing an early diagnosis of allergic bronchopulmonary aspergillosis in children. Allergy Proc 10:63-69, 1989.
12. Vithayasai V, Hyde JS, and Floro L. Allergic aspergillosis in a family. Ill Med J 144:564-566,1973.
13. Chetty A, Bhargava S, and Jain RK. Allergic bronchopulmonary aspergillosis in Indian children with bronchial asthma. Ann Allergy 54:46-49, 1985.
14. Ragosta KG, Clayton JA, Cambareri CB, and Domachowske JB. Allergic bronchopulmonary aspergillosis masquerading as pulmonary tuberculosis. Pediatr Infect Dis J 23:582-584, 2004.
15. McCarthy DS, and Pepys J. Allergic broncho-pulmonary aspergillosis Clinical immunology: (1) Clinical features. Clin Allergy 1:261-286, 1971.
16. Becker JW, Burke W, McDonald G, et al. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest 109:1536-1540, 1996.
17. Skov MT, Pressler T, Jensen HE, et al. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 54:44-50, 1999.
18. Geller DE, Kaplowitz H, Light MJ, and Colin AA. Allergic bronchopulmonary aspergillosis in cystic fibrosis: Reported prevalence, regional distribution, and patient characteristics. Chest 116:639-646, 1999.
19. Zeaske R, Bruns WT, Fink JN, et al. Immune responses to Aspergillus in cystic fibrosis. J Allergy Clin Immunol 82:73-77, 1988.
20. Skov M, Koch C, Reimert CM, and Poulsen LK. Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis. Allergy 55:50-58, 2000.
21. Nepomuceno IB, Esrig S, and Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis: Role of atopy and response to itraconazole. Chest 115:364-730, 1999.
22. Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis-State of the art: Cystic Fibrosis Foundation Consensus Conference. CI 37:S225-S264, 2003.
23. Mastella G, Rainisio M, Harms HK, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Eur Respir J 16:464-471, 2000.
24. Slavin RG. ABPA in CF: A devastating combination. Pediatr Pulmonol 21:1-2, 1996.
25. Greenberger PA, Patterson R, Ghory AC, et al. Late sequelae of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 66:327-335, 1980.
26. Lee TM, Greenberger PA, Patterson R, et al. Stage V (fibrotic) allergic bronchopulmonary aspergillosis: A review of 17 cases followed from diagnosis. Arch Intern Med 147:319-323, 1987.
27. Ricketti AJ, Greenberger PA, and Patterson R. Immediate-type reactions in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 71:541-545, 1983.
28. Patterson R, Greenberger PA, Radin RC, and Roberts M. Allergic bronchopulmonary aspergillosis: Staging as an aid to management. Ann Intern Med 96:286-291, 1982.
29. Patterson R, Greenberger PA, Lee TM, et al. Prolonged evaluation of patients with corticosteroid-dependent asthma stage of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 80:663-668, 1987.
30. Greenberger PA, Miller TP, Roberts M, and Smith LL. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy 70:333-338, 1993.
31. Chauhan B, Santiago L, Hutcheson PS, et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin 106:723-729, 2000.
32. Chauhan B, Hutcheson PS, Slavin RG, and Bellone CJ. MHC restriction in allergic bronchopulmonary aspergillosis. Front Biosci 8:S140-S148, 2003.
33. Slavin RG, Hutcheson PS, Chauhan B, and Bellone CJ. An overview of allergic bronchopulmonary aspergillosis with some new insights. Allergy Asthma Proc 25:395-399, 2004.
34. Knutsen AP, Noyes B, Warrier MR, and Consolino J. Allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis: Diagnostic criteria when the IgE level is less than 500 IU/mL. Ann Allergy Asthma Immunol 95:488-493, 2005.
35. Segal BH. Mouldy oldy: How fungus lives among us. Blood 105:2239-2240, 2005.
36. Stanzani M, Orciuolo E, Lewis R, et al. Aspergillus fumigatus suppresses the human cellular immune response via gliotox-in-mediated apoptosis of monocytes. Blood 105:2258-2265, 2005.
37. Dougherty CM, Pyper GP, and Frasz HA. Description of a nursing intervention program after an implantable cardioverter defibrillator. Heart Lung 33:183-190, 2004.